TY  - JOUR
T1  - THE EFFECT OF SILENCING THE Tip60 GENE ON THE RESPONSE TO RADIOTHERAPY IN BREAST CANCER CELLS
TT  - THE EFFECT OF SILENCING THE Tip60 GENE ON THE RESPONSE TO RADIOTHERAPY IN BREAST CANCER CELLS
AU  - Miser Salihoğlu, Ece
AU  - Karahalil, Bensu
AU  - Akaydın, Sevgi
PY  - 2022
DA  - August
DO  - 10.26650/JARHS2021-1133481
JF  - Journal of Advanced Research in Health Sciences
JO  - SABİAD
PB  - Istanbul University
WT  - DergiPark
SN  - 2651-4060
SP  - 42
EP  - 42
VL  - 5
IS  - S-1
LA  - en
AB  - One of the most important problems encountered in patients with triple-negative breast cancer (BC) treatment is the inadequate response of tumor tissue to treatment. The high expression of the Tip60, which is involved in the repair of DNA double-strand breaks, will increase the repair of DNA damage to be created in tumor cells, especially during the radiotherapy treatment process, thus reducing the treatment response and having a negative effect. In this study, the Tip60 gene was silenced using siRNA in MCF-7 and MDA-MB-231 cell lines, and their response to radiotherapy was monitored. To determine whether gene silencing was successful or not, Tip60 mRNA and protein expression values were measured. Cytotoxicity and DNA damage in UV-treated cells were analyzed by MTT and COMET methods, respectively. According to the results of the study, more DNA damage was observed in the MCF-7 in which the Tip60 gene was silenced and UV-treated compared to the non-Tip60 gene-silenced and UV-treated cells. On the other hand, more DNA damage was observed in the MDA-MB-321 in which the Tip60 gene was non-silenced and applied UV, compared to the cells in which the Tip60 gene was silenced. However, excessive DNA damage was already observed in the untreated MDA-MB-231. According to the results, silencing of the TiP60 gene in the MCF-7 may be beneficial in reducing resistance to radiotherapy, but no effect is expected in the MDA-MB-231. This can be explained by the fact that they are heterogeneous tumors. These data could use for future treatment development studies.
KW  - Breast cancer cells
KW  - Tip60
KW  - siRNA
KW  - Radiotherapy
KW  - Comet
N2  - One of the most important problems encountered in patients with triple-negative breast cancer (BC) treatment is the inadequate response of tumor tissueto treatment. The high expression of the Tip60, which is involved in the repair of DNA double-strand breaks, will increase the repair of DNA damage to becreated in tumor cells, especially during the radiotherapy treatment process, thus reducing the treatment response and having a negative effect. In thisstudy, the Tip60 gene was silenced using siRNA in MCF-7 and MDA-MB-231 cell lines, and their response to radiotherapy was monitored. To determinewhether gene silencing was successful or not, Tip60 mRNA and protein expression values were measured. Cytotoxicity and DNA damage in UV-treated cellswere analyzed by MTT and COMET methods, respectively. According to the results of the study, more DNA damage was observed in the MCF-7 in whichthe Tip60 gene was silenced and UV-treated compared to the non-Tip60 gene-silenced and UV-treated cells. On the other hand, more DNA damage wasobserved in the MDA-MB-321 in which the Tip60 gene was non-silenced and applied UV, compared to the cells in which the Tip60 gene was silenced.However, excessive DNA damage was already observed in the untreated MDA-MB-231. According to the results, silencing of the TiP60 gene in the MCF-7may be beneficial in reducing resistance to radiotherapy, but no effect is expected in the MDA-MB-231. This can be explained by the fact that they areheterogeneous tumors. These data could use for future treatment development studies.
CR  - Wellek S, Blettner M. On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2012;109(15):276-81
UR  - https://doi.org/10.26650/JARHS2021-1133481
L1  - https://dergipark.org.tr/en/download/article-file/2497757
ER  -